Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

Condition:   Immunotherapy Intervention:   Drug: olaparib, durvalumab, tremelimumab Sponsors:   Centre Georges Francois Leclerc;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials